GRAIL, Inc. (GRAL)
Nasdaq: GRAL · Services-Medical Laboratories · Menlo Park, CA · filing with the SEC since 2017
Who runs GRAIL, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ofman Joshua J.
Chief Executive Officer. First filing Jun 2024, latest Oct 16, 2026, 18 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2024
Officerssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ofman Joshua J. | Chief Executive Officer | Jun 2024 | Oct 16, 2026 | 23 · $15.1M |
| Freidin Aaron | Chief Financial Officer | Jun 2024 | Oct 7, 2026 | 13 · $10.0M |
| Partridge Andrew John | Chief Growth Officer | Jun 2026 | Oct 7, 2026 | 2 · $1.2M |
| Ragusa Robert P | Chief Executive Officer | Jun 2024 | Apr 9, 2026 | 10 · $12.3M |
Directorssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chase William J | director | Jun 2024 | Oct 16, 2026 | none |
| Mizell Steven | director | Jun 2024 | Oct 16, 2026 | none |
| Summe Gregory L | director | Jun 2024 | Oct 16, 2026 | none |
| Krevans Sarah | director | Oct 2024 | Jun 22, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Illumina, Inc. | 10% owner | Jun 2024 | Nov 18, 2025 | 1 · $79.9M |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.